Cambridge Investment Research Advisors’s CTO Realty Growth CTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Buy
18,929
+3,564
+23% +$72.2K ﹤0.01% 3154
2026
Q1
$284K Buy
15,365
+3,607
+31% +$67.3K ﹤0.01% 3333
2025
Q4
$216K Sell
11,758
-3,373
-22% -$57.7K ﹤0.01% 3511
2025
Q3
$247K Buy
15,131
+628
+4% +$10.6K ﹤0.01% 3302
2025
Q2
$250K Buy
14,503
+4,213
+41% +$76.2K ﹤0.01% 3133
2025
Q1
$199K Buy
+10,290
New +$200K ﹤0.01% 3212
2023
Q4
Sell
-10,593
Closed -$172K 3210
2023
Q3
$172K Sell
10,593
-2,520
-19% -$43.3K ﹤0.01% 2865
2023
Q2
$225K Sell
13,113
-782
-6% -$12.9K ﹤0.01% 2779
2023
Q1
$240K Buy
13,895
+164
+1% +$2.97K ﹤0.01% 2667
2022
Q4
$251K Buy
13,731
+623
+5% +$12K ﹤0.01% 2569
2022
Q3
$246K Buy
13,108
+205
+2% +$4.28K ﹤0.01% 2531
2022
Q2
$263K Buy
12,903
+2,883
+29% +$60.6K ﹤0.01% 2493
2022
Q1
$222K Buy
+10,020
New +$207K ﹤0.01% 2791

Other funds holding CTO

Cambridge Investment Research Advisors's CTO Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its CTO Realty Growth (CTO) stake by 23% in Q2 2026, buying an estimated $72.2K and bringing the position to 18,929 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

Cambridge Investment Research Advisors first reported a position in CTO in Q1 2022 and has held it in 13 quarters since. 220 funds tracked by Wall St. Rank hold CTO as of Q2 2026.

  • Cambridge Investment Research Advisors held 18,929 shares of CTO Realty Growth worth $407K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,564 CTO Realty Growth shares in Q2 2026, an estimated $72.2K.
  • CTO Realty Growth made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3154 holding.
  • Cambridge Investment Research Advisors first reported a position in CTO Realty Growth in Q1 2022 and has held it in 13 quarters since.
  • 220 funds tracked by Wall St. Rank held CTO Realty Growth as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.